FDC vs SANOFI: Stock Comparison

FDC Limited vs Sanofi India Limited

Live data: 22 July 2026, 3:00 PM IST • Source: NSE and company filings

Sanofi India Limited is the larger company by market capitalisation. FDC Limited shows faster revenue growth and lower leverage, while Sanofi India Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of FDC Limited and Sanofi India Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FDC is more favourable on 5 of 13 scored metrics and SANOFI on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SANOFI is the larger company
₹7,850 Cr vs ₹6,713 Cr
P/E Ratio
SANOFI has a lower P/E
0x vs 23.94x
P/B Ratio
SANOFI has a lower P/B
0x vs 2.71x
EPS
SANOFI has higher earnings per share
₹134.59 vs ₹17.3
Dividend Yield
SANOFI has a higher dividend yield
7.15% vs 2.39%
Revenue Growth (TTM YoY)
FDC has faster revenue growth
18.9% vs -11.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs -14.1%
Qtr Sales Growth
FDC has stronger quarterly sales growth
18.9% vs 9.74%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCSANOFI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCSANOFI
Live Price₹411.25₹3,411.9
Day Change-0.48%0.85%
Volume1.33 L12,943
52-Week High₹527.8₹5,955
52-Week Low₹312.95₹3,054
Distance from 52W High-22.08%-42.71%

Valuation

MetricFDCSANOFI
Market Cap₹6,713 Cr₹7,850 Cr
P/E Ratio23.94x0x
P/B Ratio2.71x0x
EPS₹17.3₹134.59
Book Value₹152.62₹325.31
Dividend Yield2.39%7.15%

Growth

MetricFDCSANOFI
Revenue Growth (TTM YoY)18.9%-11.9%
EPS Growth (TTM YoY)166.8%-14.1%
Qtr Sales Growth18.9%9.74%
Qtr Profit Growth167%22.4%

Profitability & Leverage

MetricFDCSANOFI
ROE12.5%47.1%
ROCE16.7%49.2%
Net Margin12.96%19.26%
Operating Margin15.9%24.4%
Debt to Equity0.01x0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCSANOFI
Promoter Holding69.66%0%
FII Holding1.4% 1 pp5.64% 0.09 pp
DII Holding6.31% 0.02 pp21.13% 0.18 pp
Public Holding22.63% 0.98 pp12.83% 0.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC Limited and Sanofi India Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.